Clinical trial
Effects of Conversion From Sirolimus Oral Solution to Tablets in Renal Transplant Recipients.
NCT00166842 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Conversion From Sirolimus Oral Solution to Tablets in Renal Transplant Recipients.
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- September 30, 2002
- Completion date
- Not reported
- Enrollment
- 40
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
immunosuppression, kidney transplantation, transplantation